Drugs / FSC 100/50mcg
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01324362 Comparator | Jan 2003 → Oct 2004 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FSC 100/50mcg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01324362 ↗ |
| Route | Inhaled | “Fluticasone Propionate/Sameterol DISKUS Twice Daily” NCT01324362 ↗ |